137 related articles for article (PubMed ID: 2914298)
1. Diagnostic accuracy of sialic acid in the diagnosis of malignant ascites.
Colli A; Buccino G; Cocciolo M; Parravicini R; Mariani F; Scaltrini G
Cancer; 1989 Mar; 63(5):912-6. PubMed ID: 2914298
[TBL] [Abstract][Full Text] [Related]
2. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
Gerbes AL; Xie YN; Mezger J; Jüngst D
Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.
Prieto M; Gómez-Lechón MJ; Hoyos M; Castell JV; Carrasco D; Berenguer J
Dig Dis Sci; 1988 Jul; 33(7):833-8. PubMed ID: 2837370
[TBL] [Abstract][Full Text] [Related]
4. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
[TBL] [Abstract][Full Text] [Related]
6. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
7. Elevated ascitic fluid fibronectin concentration. A non-specific finding.
Runyon BA
J Hepatol; 1986; 3(2):219-22. PubMed ID: 3794302
[TBL] [Abstract][Full Text] [Related]
8. [Fibronectin in the ascitic fluid: its diagnostic significance].
Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fibronectin as a marker of malignant ascites.
Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.
Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ
J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823
[TBL] [Abstract][Full Text] [Related]
13. Ascitic fluid alpha 1-antitrypsin.
Villamil FG; Sorroche PB; Aziz HF; Lopez PM; Oyhamburu JM
Dig Dis Sci; 1990 Sep; 35(9):1105-9. PubMed ID: 2167827
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of fibronectin in the differential diagnosis of ascites.
Colli A; Buccino G; Cocciolo M; Parravicini R; Mariani F; Scaltrini G
Cancer; 1986 Dec; 58(11):2489-93. PubMed ID: 3021317
[TBL] [Abstract][Full Text] [Related]
15. [Ascitic fluid: the value of various biological tests in the differential diagnosis between cirrhotic and neoplastic ascites].
Ghilain JM; Henrion J; Schapira M; Majois F; Beauduin M; Heller FR
Acta Gastroenterol Belg; 1990; 53(2):168-79. PubMed ID: 2267897
[TBL] [Abstract][Full Text] [Related]
16. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
17. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
18. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics.
Lu CW; Wang SS; Lee SD; Tsai YT; Lee FY; Shiesh SC; Wu SL; Lu RH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):350-6. PubMed ID: 1649678
[TBL] [Abstract][Full Text] [Related]
19. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence.
Gerbes AL; Jüngst D; Xie YN; Permanetter W; Paumgartner G
Cancer; 1991 Oct; 68(8):1808-14. PubMed ID: 1913524
[TBL] [Abstract][Full Text] [Related]
20. Ascitic fluid analysis in hepatocellular carcinoma.
Colli A; Cocciolo M; Riva C; Marcassoli L; Pirola M; Di Gregorio P; Buccino G
Cancer; 1993 Aug; 72(3):677-82. PubMed ID: 8392901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
